Charles River initially went public in 1968 on the NASDAQ and was later bought by Bausch & Lomb in 1984. In September 1999, the executive management team completed a leveraged buyout of the company. In June 2000, the company launched an initial public offering and again became a public company.
Should I buy CRL stock?
Out of 9 analysts, 6 (66.67%) are recommending CRL as a Strong Buy, 0 (0%) are recommending CRL as a Buy, 3 (33.33%) are recommending CRL as a Hold, 0 (0%) are recommending CRL as a Sell, and 0 (0%) are recommending CRL as a Strong Sell.
What happened to Charles River Laboratories?
In October 2003, Charles River Laboratories merged with Inveresk, a research company based in the United Kingdom. The company was known then as Charles River Laboratories. Inveresk specialised in clinical research and pre-clinical testing, and their main facilities are in Edinburgh, Scotland.
What kind of company is Charles River Labs?
pharmaceutical company
Is CRL stock a good buy?
Out of 9 analysts, 6 (66.67%) are recommending CRL as a Strong Buy, 0 (0%) are recommending CRL as a Buy, 3 (33.33%) are recommending CRL as a Hold, 0 (0%) are recommending CRL as a Sell, and 0 (0%) are recommending CRL as a Strong Sell. What is CRL's earnings growth forecast for 2022-2024?
Is Charles River a good company?
Good company Charles River Labs is a good place to start off, the staff is friendly and knowledgeable and they teach you everything you need to know. You always are encouraged and good opportunity for advancement. However, the pay isn't great.
Is Charles River Labs a CRO?
Preclinical Facilities With a global network of testing facilities in Europe, Canada, and the United States, we are a preclinical contract research organization (CRO) with a local touch.